在脑髓母细胞瘤中,MAP4激酶调节的CLSTN1表达减少与侵入性增加有关
Ece Sönmez1, Shen Yan1, Meng-Syuan Lin1
1Children's Research Center, Division of Oncology, University Children's Hospital Zürich, Zürich, Switzerland.
Scientific reports
|January 6, 2025
概括
卡尔辛宁1 (CLSTN1) 在儿科脑髓母细胞瘤 (MB) 中降低. 较低的CLSTN1水平促进瘤的侵入性,而MAP4激酶在细胞接触时降低CLSTN1,影响瘤微环境相互作用.
科学领域:
- 神经瘤学神经瘤学
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 脑髓母细胞瘤 (MB) 的生长与异常蛋白质表达和神经前分化受损有关.
- 氨1 (CLSTN1) 是一种神经元蛋白质,涉及到细胞相互作用和突触信号传递.
- 之前的研究发现CLSTN1是MAP4K4的目标,MAP4K4是一种减少CLSTN1表面表达的激酶.
研究的目的:
- 为了研究CLSTN1在脑髓母细胞瘤中的表达和功能作用.
- 了解MAP4激酶如何影响CLSTN1的表达和局部化.
- 探索CLSTN1在瘤微环境相互作用中的作用.
主要方法:
- 在初级MB瘤和细胞系中分析CLSTN1表达.
- 对CLSTN1.1的细胞局部化研究.
- 功能性测试评估通过CLSTN1操纵的侵入性.
- 药理上抑制MAP4激酶的作用.
- 与MB细胞和星体细胞进行共同培养实验.
主要成果:
- 与正常脑组织相比,CLSTN1表达在初级MB瘤中显著降低.
- 减少CLSTN1的表达增强了MB细胞的生长因子驱动的侵入性.
- 抑制MAP4激酶会增加CLSTN1的表达和在细胞与细胞接触时的积累.
- 通过天体细胞共同培养和MAP4K抑制,细胞与细胞接触处的CLSTN1定位得到增强.
结论:
- 在脑髓母细胞瘤中,CLSTN1 作为增长因子驱动的侵入性抑制剂.
- MAP4激酶对CLSTN1的细胞与细胞接触的招募进行负面调节.
- CLSTN1参与了脑髓母细胞瘤与微环境相互作用的酶介导调节.
相关概念视频
01:19Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
01:45Destabilization of Microtubules
2.6K
The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
2.6K
03:03mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
02:34Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
02:23Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K